Yeah it is. 1 mil revenue last year. Much more projected this year. Hopefully the market becomes more favorable towards spec stocks.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025